Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases

NCT00438958

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +61 more
Locations
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • Institute of Medical and Veterinary Science Adelaide, South Australia, Australia
  • Royal Melbourne Hospital Parkville, Victoria, Australia
  • Vancouver Hospital and Health Science Center Vancouver, British Columbia, Canada
View all 16 locations
View Trial Details
Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction

NCT00499811

Conditions
Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +112 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • National Institutes of Health Bethesda, Maryland, United States
View Trial Details
Completed

Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only

NCT00950911

Conditions
Blood Protein Disorders, Bone Metastases in Men With Hormone-Refractory Prostate Cancer, Bone Metastases in Subjects With Advanced Breast Cancer, +28 more
Locations
  • Research Site Jindřichův Hradec, Czechia
  • Research Site Kroměříž, Czechia
  • Research Site Olomouc, Czechia
  • Research Site Prague, Czechia
View all 17 locations
View Trial Details

Related conditions